Apyx Medical Corporation Common Stock earnings per share and revenue
On Nov 06, 2025, APYX reported earnings of -0.05 USD per share (EPS) for Q3 25, beating the estimate of -0.10 USD, resulting in a 52.20% surprise. Revenue reached 12.88 million, compared to an expected 12.24 million, with a 5.18% difference. The market reacted with a +6.69% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 7 analysts forecast an EPS of -0.06 USD, with revenue projected to reach 18.24 million USD, implying an increase of 20.00% EPS, and increase of 41.63% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
High Tide Inc. Common Shares
Report Date
Jan 29, 2026 For Q4 25
Estimate
$0.00
Actual
$0.01
Surprise
0.00%
Abbott Laboratories
Report Date
Jan 22, 2026 For Q4 25
Estimate
$1.51
Actual
$1.50
Surprise
-0.75%
Stryker Corporation
Report Date
Jan 29, 2026 For Q4 25
Estimate
$4.43
Actual
$4.47
Surprise
+0.69%
ResMed Inc.
Report Date
Jan 29, 2026 For Q2 26
Estimate
$2.75
Actual
$2.81
Surprise
+2.15%
FAQ
What were Apyx Medical Corporation Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Apyx Medical Corporation Common Stock reported EPS of -$0.05, beating estimates by 52.2%, and revenue of $12.88M, 5.18% above expectations.
How did the market react to Apyx Medical Corporation Common Stock's Q3 2025 earnings?
The stock price moved up 6.69%, changed from $3.14 before the earnings release to $3.35 the day after.
When is Apyx Medical Corporation Common Stock expected to report next?
The next earning report is scheduled for Mar 11, 2026.
What are the forecasts for Apyx Medical Corporation Common Stock's next earnings report?
Based on 7
analysts, Apyx Medical Corporation Common Stock is expected to report EPS of -$0.06 and revenue of $18.24M for Q4 2025.